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The ubiquitin ligase CHIP (C-terminus of Hsc70-interacting protein) is encoded by
STUB1 and promotes ubiquitination of misfolded and damaged proteins. CHIP
deficiency has been linked to several diseases, and mutations in the human STUB1
gene are associated with recessive and dominant forms of spinocerebellar ataxias
(SCAR16/SCA48). Here, we examine the effects of impaired CHIP ubiquitin ligase
activity in zebrafish (Danio rerio). We characterized the zebrafish stub1 gene and Chip
protein, and generated and characterized a zebrafish mutant causing truncation of the
Chip functional U-box domain. Zebrafish stub1 has a high degree of conservation
with mammalian orthologs and was detected in a wide range of tissues in adult
stages, with highest expression in brain, eggs, and testes. In the brain, stub1 mRNA
was predominantly detected in the cerebellum, including the Purkinje cell layer and
granular layer. Recombinant wild-type zebrafish Chip showed ubiquitin ligase activity
highly comparable to human CHIP, while the mutant Chip protein showed impaired
ubiquitination of the Hsc70 substrate and Chip itself. In contrast to SCAR16/SCA48
patients, no gross cerebellar atrophy was evident in mutant fish, however, these fish
displayed reduced numbers and sizes of Purkinje cell bodies and abnormal organization
of Purkinje cell dendrites. Mutant fish also had decreased total 26S proteasome
activity in the brain and showed behavioral changes. In conclusion, truncation of
the Chip U-box domain leads to impaired ubiquitin ligase activity and behavioral
and anatomical changes in zebrafish, illustrating the potential of zebrafish to study
STUB1-mediated diseases.
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INTRODUCTION
C-terminus of Hsc70-interacting protein (CHIP), encoded by
the STUB1 (STIP1 homology and U-box containing protein 1)
gene, is a dimeric co-chaperone that negatively regulates the
efficiency of Hsp70 and Hsp90 chaperones by interfering with
the ATPase cycles of the folding process (Ballinger et al., 1999).
CHIP was the first ubiquitin ligase to be directly associated with
molecular chaperones (McDonough and Patterson, 2003). The
N-terminal TPR (tetratricopeptide repeat) domain is responsible
for the interaction of CHIP with molecular chaperones, while
the C-terminal U-box domain acts as an E3 ubiquitin ligase
and facilitates ubiquitination of chaperone substrates for further
proteasomal degradation (McDonough and Patterson, 2003). In
addition, a central helical hairpin (HH) region together with
another interacting surface in the U-box domain are involved
in the dimerization and stability of CHIP (Zhang et al., 2005).
CHIP is also known to have self-ubiquitination activity, which is
independent of target ubiquitination and regulates CHIP ligase
activity and turnover (Murata et al., 2001).
CHIP is ubiquitously expressed with highest levels in
metabolically active tissues such as heart, brain, and skeletal
muscles (Ballinger et al., 1999). Analysis of CHIP expression
and localization in the rodent brain (Anderson et al., 2010; Shi
et al., 2013) suggested co-localization of CHIP with the calcium-
binding protein calbindin in cerebellar Purkinje cells of the
cerebellum as the critical elements of precise motor coordination
(Shi et al., 2013).
The dual activity of CHIP both in the ubiquitin-proteasome
pathway and as a molecular co-chaperone have made CHIP
a major player in the cellular protein quality control (PQC)
system (Paul and Ghosh, 2015; Joshi et al., 2016). Studies on
CHIP knockdown and knockout mouse models have shown
that CHIP participates in the regulation of cellular senescence
and mammalian longevity (Min et al., 2008). In addition, CHIP
is involved in many signaling pathways and dysregulation of
CHIP function has been implicated in several human diseases
including cancers (Cheng et al., 2018; Tang et al., 2019), cardiac
diseases (Naito et al., 2010; Cao et al., 2016), and other stress-
related pathologies (Joshi et al., 2016). Moreover, mutations of
CHIP causing inability to target protein substrates result in the
formation of protein aggregates, and have been associated with
the development of many neurodegenerative disorders including
Alzheimer’s (Dickey et al., 2006), Parkinson’s (Tetzlaff et al.,
2008), and polyglutamine diseases (Jana et al., 2005; Williams
et al., 2009).
Several mutations in the STUB1 gene have been reported in
patients with recessive and dominant cerebellar ataxias (CA)
(Ravel et al., 2021). CAs comprise a wide range of inherited
and sporadic human neurodegenerative disorders in which
progressive degeneration of the cerebellum results in poor
balance and aberrant movement (Hersheson et al., 2012). So
far, more than 30 STUB1 mutations have been identified in
patients with autosomal recessive spinocerebellar ataxia type 16
(SCAR16) (Stenson et al., 2017; Ravel et al., 2021). SCAR16 is
characterized by early onset cerebellar ataxia, often associated
with cognitive impairment and secondary infertility as a result of
hypogonadotropic hypogonadism (De Michele et al., 2020). Very
recently, heterozygous mutations in STUB1 have been reported
to cause dominant spinocerebellar ataxia type 48 (SCA48) (Ravel
et al., 2021), which is characterized by a later age of onset
and a wide range of variably associated phenotypes including
parkinsonism, cognitive-psychiatric disorder, chorea, epilepsy,
and endocrine dysfunctions (De Michele et al., 2020).
Insight into the pathological mechanisms associated with
STUB1 mutations is growing (Shi et al., 2013, 2014; Casarejos
et al., 2014; Heimdal et al., 2014). We previously described the
in vitro structural properties of selected STUB1 recessive and
dominant mutations, illustrating the substantial effects some of
these mutations had on the stability and dimerization of CHIP
(Pakdaman et al., 2017, 2021). However, molecular mechanisms
and pathways affected by mutant CHIP proteins leading to
human diseases remain largely unanswered.
In this study, we used zebrafish model to analyze the
putative pathogenic role of the U-box domain in CHIP-mediated
diseases. Mutations in the U-box domain have been reported
for SCAR16/SCA48 patients and it is believed that dysfunction
of the E3 ubiquitin ligase activity encoded by this domain is a
key mechanism in the pathogenesis of these variants (Madrigal
et al., 2019). For example, the SCAR16 variant, p.Thr246Met,
was suggested to cause severe ataxia associated with cognitive
deficiencies and hypogonadism in patients through loss of CHIP
function to polyubiquitinate both chaperone-bound proteins and
chaperone themselves (Shi et al., 2014). We first characterized the
wild-type STUB1 zebrafish ortholog (stub1) expression pattern
and Chip protein function. Next, we generated the first zebrafish
mutant for stub1 by truncation of the Chip functional U-box
domain by CRISPR/Cas9 technology. Wild-type zebrafish Chip
showed ubiquitin ligase activity comparable to the mammalian
orthologs in human and mouse, while homozygous mutants with
truncated U-box domain had impaired ubiquitin ligase activity.
Further, we showed that the lack of a functional U-box domain
led to morphological changes in the Purkinje cell bodies and
dendrites as well as reduced activity of 26S proteasome in the
mutant brains. Mutant fish also displayed a significant decrease
in body size and an altered pattern of explorative behavior
associated with reduced anxiety.
MATERIALS AND METHODS
Zebrafish Maintenance
Wild-type zebrafish (Danio rerio) with the TAB genetic
background (cross between AB and Tübingen strains) were
used. Zebrafish were maintained in the animal facility at the
Department of Biological Sciences, University of Bergen, under
standard conditions as described elsewhere (Aleström et al.,
2019). In brief, fish were kept at 28.5◦C in a 14 h/10 h light/dark
cycle. All the experiments were conducted in compliance with
the Norwegian Animal Welfare Act guidelines, Mattilsynet
(FOTS application with FDF reference No. 17/119996). Fin
clipping and body size measurements were performed on
fish that were previously anesthetized in 164 mg/L Tricaine
methanesulfonate solution.
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C-Terminus of Hsc70-Interacting Protein
Structural Alignments
CHIP protein sequences for humans (H. sapiens), zebrafish
(D. rerio), mouse (M. musculus), rat (R. norvegicus), chicken
(G. gallus), frog (X. tropicalis), pufferfish (T. rubripes), and
Japanese rice fish (O. latipes) were obtained from NCBI
reference sequence database (O’Leary et al., 2016), and
aligned using T-Coffee multiple sequence alignment tool
(Notredame et al., 2000).
Expression and Purification of
Recombinant Zebrafish Chip Protein
Full-length stub1 cDNA was amplified from wild-type and
mutant zebrafish brain total cDNA, and the NcoI and NotI
restriction sites were introduced by using gene-specific forward
(5′-CCATGGAGAAGATGGCGAGCAGCCCAGAG-3′) and
reverse (5′-GCGGCCGCGTAGTCCTCCACCCAG-3′) primers
and Advantage PCR kit (Takara Bio Inc., Shiga, Japan).
Resulting fragments were cloned into the pCRII-TOPO vector
using the TOPO TA Cloning Kit (Thermo Fisher Scientific,
MA, United States). Positive colonies were used for further
sub-cloning into the prokaryotic expression vector pETM41
(EMBL, Heidelberg, Germany). The NcoI/NotI-digested stub1
insert was ligated into the pETM41 vector using T4 DNA
ligase (New England BioLabs, MA, United States). His-MBP-
fusion Chip proteins were expressed in BL21-CodonPlus
(DE3)-RP competent cells and purified as described previously
(Pakdaman et al., 2017). The His-MBP-tagged proteins were
stored in 100 mM HEPES, 100 mM NaCl, 5 mM DTT,
and 10% glycerol.
In vitro Ubiquitination Activity and
Immunoblotting
In vitro ubiquitination reactions were performed on recombinant
zebrafish and human CHIP as previously described (Pakdaman
et al., 2017). Human CHIP proteins were purified from the
bacterial expression vector pETM41, which was previously
prepared by cloning CHIP full length cDNA from purchased
vector pMXs.EXBi-STUB1-IRES-Puro (Cyagen Bioscience Inc.,
California) (Heimdal et al., 2014).
CHIP ubiquitination activity was tested for 2.5 µg of CHIP
proteins during 1 h incubation at 37◦C in the presence of 1 µg
recombinant human His-HSPA8 (HSC71) (Lifespan Biosciences,
WA, United States) and other components of ubiquitination
reaction. Immunoblotting analyses were performed, using anti-
HSC70/HSP73 (1:10,000, Cat. ADI-SPA-815, Enzo Life Sciences,
Inc., NY, United States) and anti-CHIP antibody (1:2,000, Cat.
C9243, Sigma-Aldrich, MO, United States) antibodies.
RNA Extraction
A tissue panel containing heart, liver, skin, intestines, gonads,
brain, thyroid, and head kidney of 2 years old zebrafish
were subjected to RNA extraction by homogenization
of frozen tissues in Trizol reagent using a Precellys 24
homogenizer (Bertin instruments, program: 5000-1 × 15-
005). Phase separation was induced by adding chloroform,
and the upper aqueous phase (RNA) was isolated by
isopropanol. Additional RNA precipitation was performed
in 0.1× volume of 3 M sodium acetate, pH 5.2 and 2.5× volume
of 100% ethanol.
Reverse Transcription and Droplet Digital
PCR
First-strand cDNA was synthesized from 100 ng of total RNA
using the Superscript III reverse transcriptase kit (Invitrogen,
CA, United States). The ddPCR reaction was prepared in a
mixture containing 2x QX200 ddPCR EvaGreen Supermix
(Bio-Rad Laboratories, CA, United States), 0.25 µM forward
(5′-GAGCTGCACGCCTATCTCAG-3′) and reverse (5′-
CAGGTAATCGGGGATCTCGC-3′) primers, as well as 15 ng
of cDNA templates. No-template control (NTC) and no-reverse
transcriptase (NRT) reactions were included as negative controls
in each run. Droplets of each sample were generated from
20 µl of reaction mixture and 70 µl of droplet generation oil
(Bio-Rad) in the QX200 Automated Droplet Generator with
DG8 cartridges (Bio-Rad). PCR amplification was carried out
on 40 µl of generated sample droplets in heat-sealed 96-well
plates using the C1000 thermal cycler (Bio-Rad) and the thermal
profile (with ramping rate of 2◦C/s): 95◦C for 5 min, 40 cycles
of denaturation at 95◦C for 30 s and annealing at 60◦C for 60 s,
followed by 5 min cooling at 4◦C, 1 cycle of 90◦C for 5 min, and
final hold at 4◦C. Transcripts of stub1 were quantified by using
QuantaSoft analysis software (Bio-Rad) on the QX200 Droplet
Reader (Bio-Rad) at a rate of 32 wells/h. Data were normalized
to the negative controls and the number of specific copies per
ng of initial cDNA was calculated for each sample. Graphical
illustrations were prepared by GraphPad Prism version 8.4.2.
cRNA Probe Synthesis
pExpress-1 vectors containing complete stub1 cDNA sequence
(ENSDART00000145075.3, ensemble genome database;
Ensembl release 102—November 2020) was purchased (Source
BioScience, Nottingham, United Kingdom) and verified by
Sanger sequencing. Sense- and anti-sense cRNA probes were
synthesized for 687 bp zebrafish stub1 sequence (C70-C755)
following plasmid linearization with NotI (New England
BioLabs) and EcoRV (New England BioLabs) restriction
enzymes, respectively, and purification of PCR-amplified
stub1 cDNA fragments containing SP6 (NotI-digested) and
T7 (EcoRV-digested) promoter sites. PCR reactions were
prepared by using forward and reverse primers for T7-
(forward: 5′-CTGTTCCTCAGCCGCAAGTA-3′, reverse: 5′-
TAATACGACTCACTATAGGGGTCAAAATGGCCAACACGC
T-3′) and SP6- (forward: 5′-ATTTAGGTGACACTATAGAA
CTGTTCCTCAGCCGCAAGTA-3′, reverse: 5′-GTCAAAAT
GGCCAACACGCT-3′) containing fragments. Probe synthesis
was performed using Digoxigenin (DIG) RNA labeling kit
(Roche Molecular Biochemicals, Basel, Switzerland) and 400
ng of PCR product as template. Transcription reactions were
terminated by addition of EDTA on ice, and cRNA probes were
precipitated in a solution of 0.1 × volume of 4 M LiCl, 3.7 µg/µl
tRNA (Roche), and 3× volume of 100% ethanol.
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In situ Hybridization
TissueTek-embedded brains of adult zebrafish were
cryosectioned (8 µm) on Superfrost Plus slides (Thermo
Fisher Scientific) serially in the sagittal plane using a Leica
CM3050S cryostat (Leica Biosystems, Wetzlar, Germany).
In situ hybridization was performed as previously described
(Sandbakken et al., 2012). Briefly, the sections were
fixed in 4% paraformaldehyde and hybridized with stub1
cRNA probes overnight at 65◦C. For immunodetection,
sections were incubated with sheep anti-DIG-AP antibody
(1:2,000, Cat. 11093274910, Sigma-Aldrich) and color
development was obtained during 30 min to 4 h incubation
of sections in 4-nitro blue tetrazolium chloride and 5-
bromo-4-chloro-3-indolyl phosphate-4-toluidine salt
(Sigma-Aldrich) in the dark. After termination of the
visualization reaction, the sections were mounted in 70%
glycerol. In situ hybridization graphs were taken by Leica
M420 microscope (Leica Microscope Systems), followed by
digital processing.
CRISPR/Cas9 Constructions
Potential target sites were identified within the stub1 gene by
using zifit1 and CHOP-CHOP2 webtools. Candidate sites were
blasted against the whole genome of zebrafish3,4 and checked
by using CHOP-CHOP and Integrated DNA Technology5 tools
for the presence of off-targets. Single guide RNA (sgRNA) was
prepared for the selected target site following instructions by
Gagnon et al. (2014). In brief: stub1 target site-specific oligo
(5′-AGGTCAGAGGACTACGCGTGA-3′) was designed as
a 60-base pair oligonucleotide containing an upstream T7
promoter (5′-TAATACGACTCACTATA-3′) and a downstream
overlapping region (5′-GTTTTAGAGCTAGAAATAGCAAG-3′)
which anneals to a constant oligonucleotide (5′-
AAAAGCACCGACTCGGTGCCACTTTTTCAAGTTGATAAC
GGACTAGCCTTATTTTAACTTGCTATTTCTAGCTCTAAAA
C-3′) by mixing at the final concentrations of 20 µM, and during
the PCR program: denaturation for 5 min at 95◦C, decreasing
temperature to 85◦C by −2◦C/s and then to 25◦C by −0.1◦C/s,
and indefinite hold at 4◦C. T4 DNA polymerase (300 units/ml,
New England BioLabs) was used to fill in the annealed strands
during 20 min incubation at 12◦C. The reaction was terminated
by adding the final concentration of 20 mM EDTA on ice
followed by 20 min incubation at 75◦C. DNA templates were
further purified by using QIAquick PCR purification kit (Qiagen,
Hilden, Germany), and products of the correct size were verified
by DNA agarose gel electrophoresis. Transcription of sgRNAs
were performed by using Amibon MEGAscript T7 Transcription






Microinjection and Development of
Homozygous Mutant Fish
Zebrafish embryos were injected at the one-cell stage with 2–
3 nl of a mixture containing 600 ng/µl Cas9 protein (PNA Bio
Inc., CA, United States), 200 ng/µl sgRNA, and 300 mM KCl.
Injection solutions were prepared on ice and incubated at 37◦C
prior to injection. Around 20 injected embryos (F0 generation)
were collected at 48 h post fertilization (hpf) and screened for
the presence of induced mutations around the target site (section
“Genomic DNA Extraction and Genotyping”). The F0 generation
were crossed with wild-type zebrafish (TL) at 3 months old.
Male and female F1 fish with identical genotypes were crossed
to generate the F2 homozygous mutants.
Genomic DNA Extraction and
Genotyping
Genomic DNA was extracted from individual zebrafish embryos
and tail-cuts using standard protocols. Amplification of target
sites was performed in a PCR reaction containing 0.2 µM
forward (5′-TCTCCATTAATGAGCAGTTGGA-3′) and reverse
(5′-ATGAAAGCGTCGATCACCTC-3′) primers, following the
PCR program: 3 min of denaturation at 96◦C, 35 cycles of
amplification (96◦C for 30 s, 55◦C for 30 s, and 72◦C for 30 s),
final extension at 72◦C for 10 min, and indefinite hold at 4◦C.
PCR products were further digested by 10 units/ml of MluI-HF
restriction enzyme (New England BioLabs), and visualized on a
2.5% agarose gel.
Targeted Gene Sequencing
A StrataClone PCR Cloning kit (Agilent, CA, United States) was
used to clone PCR products of the target site into the pSC-
A-amp/kan vector, and further transform the cloning products
into E. coli competent cells (provided by the kit). Positive
clones were identified by PCR analysis of selected colonies,
using 0.5 µM T3 (5′-GCAATTAACCCTCACTAAAGGGA-3′)
and T7 (5′-CCCTATAGTGAGTCGTATTA-3′) primer pair. PCR
conditions were set up as follows: 10 min of denaturation
at 94◦C, 35 cycles of amplification (94◦C for 30 s, 48◦C for
30 s, and 72◦C for 30 s), final extension at 72◦C for 10 min,
and indefinite hold at 4◦C. PCR reactions were cleaned and
sequenced by using illustra ExoProStar (Sigma-Aldrich) and 0.5
µM T3 primer. Sequencing was performed using an Applied
Biosystems 3730 capillary sequencer (Applied Biosystems, CA,
United States) at the Department of Medical Genetics, Haukeland
University Hospital, Bergen, Norway. Results were analyzed by
using SnapGene software (GSL Biotech LLC).6
Zebrafish Magnetic Resonance Imaging
Magnetic resonance imaging (MRI) of zebrafish was performed
on a 7T small animal MRI scanner (Bruker, MA, United States),
with a 760 mT/m actively shielded imaging gradient insert.
A 72 mm diameter transmit coil together with a phased array
surface RF receive-only coil were used for excitation and
detection of the MR signal. The system was connected to a Linux
6snapgene.com
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PC running Paravision 6.0.1 software (Bruker). Adult zebrafish
were euthanized and placed in a 3D-printed plastic mold.
High-resolution T2-weighted images were acquired by using
TurboRARE (rapid acquisition with relaxation enhancement)
spin-echo sequences with echo time 28.2 ms; repetition time
2,000 ms; RARE factor 8; slice thickness 0.2 mm; number of slices
12; field-of-view 8 × 4.5 mm; image matrix 200 × 112 pixels,
resulting in an in-plane resolution of 40 um with 200 averages.
26S Proteasome Activity Assay
The 26S proteasome activity was measured as described
previously by Kristiansen et al. (2007). In brief, zebrafish
brain tissues were lysed and treated with 50 U/ml Benzonase
Nuclease (Sigma-Aldrich) for 15 min on ice to digest nucleic
acids. Ten micrograms of extracted protein were added to
100 µl proteasome reaction buffer containing 57 mM fluorogenic
substrate SUC-LLVY-AMC (Sigma-Aldrich). Fluorescence was
measured every minute for 60 min at 37◦C using TECAN
96 well-plate reader (Tecan, Mannedorf, Switzerland) with
the excitation/emission wavelengths of 360/440 nm. Non-
specific substrate hydrolysis was measured by pre-incubation of
proteins with 50 mM of the proteasome inhibitor Epoxomicin
(Sigma-Aldrich) for 30 min at 37◦C, and subtracted from
each measurement. The corresponding corrected fluorescence
measurements were plotted against time and the 26S proteasome
activity was determined by calculating the slope of the
regression line.
Dot Blot Analysis
Soluble proteins were extracted from zebrafish brains in
phosphate-buffered saline containing 100x Protease Inhibitor
Cocktail (Sigma-Aldrich) under native conditions. Ten
micrograms of protein were directly loaded onto a nitrocellulose
membrane and blotted by A11 anti-oligomer antibody (Cat.
AHB0052, Thermo Fisher Scientific). Recombinant wild-type
and Thr246Met mutant human CHIP proteins (Pakdaman et al.,
2017) were used as controls for negative and positive aggregation,
respectively. Loading control samples were prepared by 10 min
incubation of proteins at 72◦C prior to loading, and subsequent
blotting by anti-beta actin antibody (Cat. ab209869, Abcam,
Cambridge, United Kingdom).
Immunohistochemistry
For immunostaining, anti-parvalbumin (1:200, Millipore
MAB1572), anti-Ataxin-3 (1:100, GeneTex GTX115032), anti-
HSP70/73 (1:50, LSBio LS-B3700), and anti-Grin2a (NR2A)
(1:100, Creative Diagnostics CPBT-66734RR) were used as
the primary, and the anti-mouse Alexa Fluor Plus 555 (1:400,
Cat. A32727, Thermo Fisher Scientific) and anti-rabbit Alexa
Fluor Plus 488 (1:400, Thermo Fisher Scientific A32731) were
used as secondary antibodies. Antibodies were diluted in
PBST (PBS + 0.05% Triton X-100), 1x Casein Blocking Buffer
(Sigma-Aldrich) before use. Cryosections (8 µm) were air-dried
and washed with PBST before the primary antibody was added
to the samples for overnight incubation at RT. The samples
were then washed with PBST, and incubated in the secondary
antibody for 45 min at RT. The slides were mounted using
ProLong Glass medium containing NucBlue nucleic acid dye
(Invitrogen). Analysis of cell death (TUNEL) was performed
on cryosections by using the In situ Cell Death Detection Kit,
Fluorescein (Roche).
Fluorescent images were obtained by TCS SP5 II confocal
microscope (Leica Microsystems) and an Axio Scan.Z1 slide
scanner (Carl Zeiss AG, Oberkochen, Germany). Images were
processed using ImageJ (Schneider et al., 2012), and Alexa Fluor
555, Alexa Fluor 488, and NucBlue signals were pseudo-colored
red, green and blue, respectively.
Dendrite Orientation Analysis
NeuTube software (Feng et al., 2015) was used for neuronal
tracing, using the anti-parvalbumin fluorescent signal on
confocal-acquired z-stacks of the posterior cerebellum. Resulting
3-D rendered pictures were displayed using a perspective
projection positioned at the origin of all axes, with neurons
displayed as lines and selecting “direction” as a color mode.
To quantity dendrite orientation, coded under that mode as a
continuous gradient from green [0◦–parallel to proximo-distal
(P-D) axis] to red (90◦–perpendicular to the P-D axis) through
yellow (i.e. same amount of red and green, 45◦), we generated
RGB histograms of these pictures along their Y-(P-D) axis, using
Image J. From these histograms, the difference between total red
and green signals for each pixel row of the picture was calculated
and plotted as absolute values, and on the resulting graphs, the
total area of the predominantly green or red areas was measured
to determine trends in dendrite orientation along the P-D axis.
Morpho-Anatomical Quantification
To measure the average number of Purkinje cell bodies per
individual, we analyzed wild-type and mutant zebrafish at 6
(wild-type: n = 3; mutant: n = 6) and 24 (wild-type: n = 3;
mutant: n = 6) months of age. Parvalbumin-positive cell bodies
were manually and blindly counted on three sagittal sections
per individual, using the ImageJ Cell counter tool. The sections
were imaged by a slide scanner in similar positions for each
individual, covering adjacent and sequential positions along
the medio-lateral axis. The average cross-section cell area was
measured manually by ImageJ freehand drawing tool on three
sagittal sections per individual. The number of Purkinje cell
dendritic spines was quantified by using the LAS X software
(Leica Microsystems). Spines along a 10 µm area of dendrites
were manually counted on 9–10 dendrites in both wild type
and mutants and the average of the dendritic spines per µm
was calculated. Quantification of the dendrite diameter was
performed by measuring the diameter at 9–10 random points
along 10 µm of dendrites on 9–10 dendrites in both wild type and
mutants. Dendritic spines were excluded in the measurement of
the dendrite diameter, and the number of dendrites was chosen
based on the visibility of dendrites.
Behavioral Analysis
Behavioral experiments were conducted on adult zebrafish at 12
and 24 months of age in a dedicated zebrafish room with constant
illumination and temperature (28◦C). Behavioral recordings
were captured using a digital camera (Point Gray Research
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Inc., BC, Canada), and FlyCapture software version 2.5.2.3
(FLIR Systems, OR, United States). EthoVision XT12 (Noldus
Information Technology, Wageningen, Netherland) was used for
video tracking. Quantification and analyses were performed blind
to the genotype of the fish being examined.
For the novel tank diving test (Egan et al., 2009), individual
fish were transferred into standard 3.5 L trapezoid tanks
[27.9 × 22.5 × 11.5 × 15 cm, L (top) × L (bottom) ×W × H],
and their behavior was immediately recorded for 5 min. The
amount of time spent in the bottom, middle, and top third
of the tank, total distance swum, angular velocity, and latency
to enter the top 25% zone of the novel tank were measured
for each fish using EthoVision software. During the light/dark
preference test, single fish were placed into a transparent plastic
tank (30 × 20 × 12 cm, L ×W × H) equally divided into black
and white zones and with the water depth of 10 cm. After 5 min
habituation, the swimming behavior of each fish was recorded
from above for 5 min, evaluating the total amount of time spent
in the white zone. The open field test was performed in an open
tank (30 × 20 × 12 cm, L ×W × H) filled with water to a depth
of 10 cm. Following 5 min habituation, the total distance swum,
the locomotor velocity, and the angular velocity were measured
for each fish during 5 min by video tracking from above.
RESULTS
Zebrafish Chip Is a Highly Conserved
Homodimer With E3 Ubiquitin Ligase
Activity
We identified one copy of the stub1 zebrafish gene in the zebrafish
genome based on searches in Ensembl7 and Uniprot8 databases,
thus our analysis refers to the gene annotated as “stub1”
in the Ensembl genome database (ENSDARG00000045228,
Ensembl release 102—November 2020). The primary structure
of the CHIP protein (Figure 1A) includes three domains: the
N-terminal TPR, the central helical hairpin (HH), and the
C-terminal U-box. A structure-based protein sequence alignment
between human, monkey, mouse, rat, chicken, frog, zebrafish
and additional fish orthologs (Figure 1B) shows that all three
domains are clearly present in all represented species. The
primary amino acid sequence identity of CHIP between zebrafish
and human is high (79%). The reported key residues for the
interaction of CHIP with Hsp70/Hsp90 molecular chaperones
and E2 enzymes (Zhang et al., 2005; Xu et al., 2006) were
found to be identical between zebrafish, mouse, and other
species (Figure 1B, marked with green background/asterisk
for E2 and red asterisk for chaperones). Likewise, the main
amino acids located at the core of U-box interfaces in the beta
sheet structures and helix 10 (Zhang et al., 2005; Xu et al.,
2006) are identical across all species (Figure 1B, marked with
blue background/asterisk), while the sequence of the helical
dimerization segment in the helix 7 and 8 varies considerably
between species (Figure 1B).
7ensembl.org/zebrafish
8uniport.org
To further investigate the functional conservation of CHIP
between human and zebrafish, we generated recombinant
full-length MBP-tagged zebrafish Chip protein (Figure 1C,
lane 1) and tested its ability to ubiquitinate itself and the
Hsc70 chaperone (Figure 1C, lanes 2–5). Western blotting
using anti-CHIP and anti-HSC70 antibodies revealed full
ubiquitination activities for zebrafish Chip (Figure 1C, lane
3 and 5) that were highly comparable to the human CHIP
control (Figure 1C, lane 2 and 4), demonstrated by a series
of high molecular bands representing ubiquitinated MBP-
CHIP and Hsc70.
stub1 RNA Is Widely Expressed in
Zebrafish
To investigate the expression pattern of stub1 in zebrafish and
compare it to mammals, we studied diverse tissues using ddPCR.
Variable levels of stub1 transcript were detected in all tissues
examined (Figure 2A and Supplementary Tables 1, 2), with
the highest level in the eggs, testis, and brain, and the lowest
levels in thyroid.
stub1 mRNA Is Present in the Purkinje
Cell Layer of the Zebrafish Cerebellum
The localization of stub1 mRNA in the brain of adult
zebrafish was investigated by in situ hybridization, using
DIG-incorporated cRNA probes. The stub1 anti-sense probe-
hybridized sections demonstrated signals in the cerebellar
corpus (Cce) and eminentia granularis (EG), including cells
in the Purkinje cell layer (PCL) and the granular layer (GL)
(Figures 2B,C). We also observed staining in valvula cerebelli
(Val) and torus longitudinalis (TL) (Figure 2B). Outside of the
cerebellum and midbrain area, we detected notable expression in
hypothalamus (Hyp) (Figure 2B). Negative controls hybridized
with the stub1 sense probes showed no staining (Figure 2D).
These results indicate the expression of stub1 mRNA in the
zebrafish cerebellum, most likely in the Purkinje cell bodies
and granular cells.
Generation of Mutant Zebrafish With
Truncated Chip U-Box Domain
Mutant fish encoding truncated Chip functional U-box domain
(U-box−/−) were generated by CRISPR/Cas9 technique. The
sgRNA was designed to target the last exon (exon 8) of the
stub1 gene (Figure 3A), which encodes the C terminal U-box
domain of Chip (Figure 3D). An F0 adult fish with the highest
frequency of mutations in its F1 offspring (77%) was selected
as founder for establishing a homozygous mutant line. After
outcrossing the founder fish, heterozygous F1 fish with a 7 bp-
deletion in the stub1 target site were identified by MluI restriction
digestion and DNA sequencing (Figures 3B,C), and crossed to
breed F2 homozygous U-box−/− mutants. The 7 nucleotide-
deletion mutation encodes a frameshift mutation at Threonine
255 and an early stop codon after encoding three amino acids
[p.Thr255Valfs∗3, removing the 28 most C-terminal residues of
the U-box domain (Figure 3D)].
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FIGURE 1 | CHIP structure and ubiquitination activity is conserved among human and zebrafish. (A) Seven exons in the structure of STUB1 gene correspond to the
TPR, helical hairpin, and U-box domains of CHIP protein. (B) Alignment of CHIP sequence from human (H. sapiens), zebrafish (D. rerio), mouse (M. musculus), rat
(R. norvegicus), chicken (G. gallus), frog (X. tropicalis), pufferfish (T. rubripes), and Japanese rice fish (O. latipes). The predicted position of secondary structures is
displayed above the corresponding amino acid sequences in orange, blue, and green boxes corresponding to the TPR, helical hairpin, and U-box domains,
respectively. Main residues involved in the U-box dimerization (in blue) as well as interactions via the TPR (in orange) and U-box (in green) domains are marked with
background color (reported in zebrafish Chip) and/or asterisks (reported in mouse CHIP). This figure was produced by using T-Coffee (Notredame et al., 2000).
(C) MBP-Chip recombinant protein was detected by Western blot analysis around 80 kDa (lane 1). Identical Hsc70- and self-ubiquitination activities were observed
for human CHIP (lanes 2 and 4) and zebrafish Chip (lanes 3 and 5), shown by multiple ubiquitinated bands above MBP-CHIP (lanes 2 and 3) and Hsc70
(lanes 4 and 5).
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FIGURE 2 | stub1 mRNAs are expressed in different tissues and in the
Purkinje cells of adult zebrafish cerebellum. (A) Scatter plot of ddPCR data
presenting the absolute number of stub1 transcripts per ng of cDNA for
different zebrafish tissues. Each dot represents a biological replicate. Means
and standard deviations are indicated by the lines and bars in the graph
(n = 4). (B) DIG-labeled stub1 cDNA probes were synthesized, and used for
visualization of stub1 mRNA expression in adult zebrafish brain sections, using
in situ hybridization assay. (C) Detailed view of cerebellum where stub1
positive cells in the Purkinje cell layer are indicated by arrowheads.
(D) Negative control corresponding to the same area as shown in (B). Tel,
telencephalon; TeO, tectum opticum; TL, torus longitudinalis; Val, valvula
cerebelli; Cce, Corpus cerebelli; EG, eminentia granularis; Mo, medulla
oblongata; Hyp, hypothalamus; A, anterior; P, posterior; D, dorsal; V, ventral;
ML, molecular layer; PCL, Purkinje cell layer; GL, granular layer.
Homozygous U-box−/− zebrafish displayed normal early
development, longevity, and breeding abilities. Homozygous
fish were raised and phenotypically characterized at 6, 12, and
24 months after fertilization.
U-Box−/− Fish Express Truncated Chip
Protein With Impaired Ubiquitin Ligase
Activity
To investigate the effects of the U-box domain truncation
on Chip E3 enzymatic activity in zebrafish, stub1 cDNA was
amplified from wild-type and U-box−/− brains, and sub-cloned
into the pETM41 bacterial expression vector. Recombinant
MBP-tagged wild-type and mutant Chip proteins were further
purified and subjected to in vitro ubiquitin ligase activity
assay (Figure 3E). Western blotting demonstrated similar
ubiquitination activities for the human CHIP control (Figure 3E,
lane 1 and 4) and wild-type zebrafish Chip (Figure 3E, lane 2
and 5) as observed by multiple bands with increasing molecular
weight. In the mutant zebrafish Chip, we observed a mono
self-ubiquitination (Figure 3E, lane 3) and complete lack of
activity on Hsc70 substrate (Figure 3E, lane 6), demonstrated
by the lack of bands with increased molecular weight. In
addition, a small molecular weight shift was observed for
the U-box−/−zebrafish MBP-Chip protein (Figure 3E, lane
3), confirming the amino acid truncation induced by the
Thr255Valfs∗3 mutation in this protein.
U-Box−/− Fish Show Progressive
Reduction of Size Compared to
Wild-Type Siblings
In order to study the progressive effect of mutant Chip on fish
growth, we measured the standard length and body weight of
wild-type and U-box−/− fish (n = 10) at 3, 6, 12, and 24-month
timepoints (Figure 4 and Table 1). The measurements were
performed blind to the fish genotypes, and the stub1 mutation
status for each fish was identified afterward. At 3 months of age,
no significant differences were detected between wild-type and
mutant fish. At 6 months, mutant fish showed a slower growth
in standard length compared to the wild-type (t-test, p = 0.03).
Significant differences in length were also observed at 12 months
(t-test, p = 0.01) and 24 months (t-test, p = 0.001), and mutant fish
at 24 months old were on average 2.8 mm shorter than their wild-
type siblings (Figures 4A,C). The weight at 3 and 6 months were
not significantly different, but a trend of decreased weight could
be observed for the mutant. However, the mutant fish showed
significantly reduced weight at 12 (t-test, p = 0.02) and 24 months
(t-test, p = 0.0005), with an average weight of 94.5 mg (t-test,
p = 0.0005) lower than their wild-type siblings at 24 months
(Figure 4B). The measurements at each state were performed on
the same number of male and female fish of each genotype to
avoid a bias toward gender on the body size differences observed
across the two groups.
Magnetic Resonance Imaging Reveals
Intact Brain Structures in the U-Box−/−
Fish
MRI of the brain was performed on adult zebrafish at 24 months
of age (n = 4). No major differences were observed for the general
structure or morphology of the brain regions between wild-
type and mutant fish (Figures 5A–C). Measurement of whole
brain area revealed no differences between mutant and wild-
type fish (Figure 5D), however, the area corresponding to the
cerebellum was slightly smaller in the mutant fish (Figure 5E,
t-test, p = 0.03746).
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FIGURE 3 | Zebrafish U-box−/− expressing truncated Chip with impaired ubiquitin ligase activity were generated by CRISPR/Cas9. Zebrafish stub1 gene was
targeted for mutagenesis at the last exon (A), leading to an introduction of 7 bp-deletion mutation in this exon (c.761-769del) which was detected by MluI restriction
digestion (B) and DNA sequencing (C). The 761-769del mutation is predicted to result in a frameshift and early stop codon and truncation of C-terminal U-box
domain (D). Recombinant Chip proteins were produced from the cDNA of U-box−/− and wild-type zebrafish, and further examined for in vitro ubiquitin ligase activity
on Chip (E, lane 1–3) and Hsc70 substrates (E, lane 4–6). Compared to the wild-type human CHIP (E, lane 1 and 4) and wild-type zebrafish Chip (E, lane 2 and 5)
controls, U-box truncated zebrafish Chips showed impaired self-ubiquitination (E, lane 3) and Hsc70 ubiquitination activities (E, lane 6).
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FIGURE 4 | U-box−/− fish are associated with smaller body size compared to their wild-type siblings. Quantification of standard length (A) and body weight (B) are
presented for wild-type and U-box−/− zebrafish in indicated age groups (n = 10). Data shown are means and error bars indicate standard deviation. Statistically
significant differences are shown by asterisks (∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001, Student’s t-test). (C) Representative images of U-box−/− and wild-type
zebrafish (female) at 24 months of age.
TABLE 1 | The standard length (mm) and body weight (mg) of wild-type and U-box−/− fish at indicated time points.
Age (month) 3 6 12 24
Standard length (mm) U-box +/+ 22.81 ± 1.9 22.5 ± 1.6 25.06 ± 1.6 26.7 ± 1.7
U-box −/− 21.48 ± 1.62 20.6 ± 1.9 22.9 ± 1.8 23.9 ± 1.7
Weight (mg) U-box +/+ 241.7 ± 77.9 202.8 ± 63.1 263.3 ± 75.4 292.1 ± 62.6
U-box −/− 189.9 ± 50.6 154.9 ± 46.5 194.2 ± 48.3 197.6 ± 34.3
Data shown are means ± standard deviations.
Chip U-Box Truncation Causes a
Disturbed Growth Pattern and
Morphology in Purkinje Cell Dendrites
We investigated the structure and organization of Purkinje
cells in the cerebellum of wild-type and mutant zebrafish at 6
(wild-type: n = 3; mutant: n = 6) and 24 (wild-type: n = 3;
mutant: n = 6) months using immunohistochemistry of sagittal
cryosections incubated with anti-parvalbumin (Pvalb) antibody
(Bae et al., 2009). We tested a panel of anti-CHIP antibodies,
both commercially available and custom made (Supplementary
Table 3), but could not identify any antibody with high
specificity for zebrafish Chip. Pvalb-positive structures were
detected in several parts of the brain at 6 and 24 months
with the strongest expression observed in the cerebellum of
both wild-type and U-box−/− fish (Figures 6Aa–Da). The
overall size of the cerebellum, as shown by the crown of Pvalb-
positive dendrites, was found to be smaller in mutant fish at
24 months (Figures 6Bb,Db) compared to the wild-type control
(Figures 6Ab,Cb). However, the ratio between the cerebellum
and other brain structures (cerebellum + telencephalon) was
unchanged (Supplementary Figure 1A). The thickness of the
molecular layer was also smaller in the mutant brains at
24 months, yet it was proportional to the size of the cerebellum
(Supplementary Figure 1B) between wild-type and mutant
brains, indicating no clear change in relative size. Altogether, we
did not observe gross signs of cerebellar atrophy in the mutants
up to 24 months.
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FIGURE 5 | Magnetic resonance imaging of wild-type and U-box−/− zebrafish brains demonstrate similar intact structures. MRI of the adult zebrafish brain at
24 months revealed no significant alterations in the overall brain structures between wild-type (A) and mutant (B) zebrafish. (C) Different regions of a wild-type
zebrafish brain are indicated on a representative MRI image. Section area of the whole brain (D,E) the relative area of different regions (D) were calculated by using
Fiji (ImageJ) software (31). Data shown are means and error bars indicate standard deviations (∗p < 0.05, Student’s t-test). Scale bars in (A–C): 1 mm. Te,
telencephalon; TeO, tectum opticum; Cce, corpus cerebelli; Mo, medulla oblongata.
In the zebrafish cerebellum, the somata of the Purkinje cells
are located in a single-celled layer. Each cell soma extends
primary dendrites into the molecular layer (ML) in a stereotypic
pattern following a single para-sagittal (translobular) plane
and arborizing into flat, fan-shaped structure with multiple
branches (Figure 6c). In the wild-type, we observed the
dendrites as long, coherent neurites visible in each section
(Figures 6Ac,Cc). In the posterior part of the cerebellum of
mutants, the dendrites appeared generally more disorganized,
and highly segmented dendrites were observed in each
section, indicating that their growth was less strictly ordered
compared to the observation in the wild-type fish. The
apparent disorganization of the Purkinje cell dendrites was
observed in the mutant brains at both examined time points
(Figures 6Bc,Dc).
To closer analyze the observed disturbances of the Purkinje
cell dendrites in mutants, we performed neuronal tracing
on the confocal images in the posterior part of cerebellum
(Figure 6d). In this analysis, the dendrites are displayed as
lines with different colors in the sagittal sections, with green
indicating growth along the proximal-distal (P-D) axis (relative
and perpendicular to the PCL) while red indicates growth
parallel to the PCL and perpendicular to the P-D axis. The
color gradient goes from parallel to the P-D axis (100% green,
0◦) to perpendicular to the P-D axis (100% red, 90◦). At 45◦,
the amount of red and green were counted as equal. In the
wild-type, dendrites were mostly orientated along the P-D axis
(green) in the distal half of the cerebellum ML, and showed
more branching away from the P-D axis (red) in the proximal
half of the ML (Figures 6Ad,Cd). This is visualized with
the color bar oriented along the proximal-distal axis of the
posterior part of the sagittal cerebellum sections (Figure 6e).
For the wild-type, the color of the bar is largely split in two
blocks, the proximal (red) and the distal (green) block, reflecting
the strongest branching proximal to the Purkinje cell bodies
(Figures 6Ae,Ce). In the mutant fish, we generally observed a
shift from growth along the P-D axis (green) toward growth
perpendicular to the P-D axis (red) in the distal part of the
ML (Figures 6Bd,Dd). We could quantify this as a reduction
of the total number of distal green dendrites (Figures 6Be,De).
This pattern was observed as a trend in 6 months old mutant
fish, while at 24 months a statistically significant reduction
was observed in the total number of distal filaments along the
P-D axis in the mutant compared to the wild-type fish (t-
test, p = 0.0093, Figure 6f). Overall, these findings indicate a
progressive disruption in the spatial organization of Purkinje cell
dendrites in U-box−/− fish with an increasing alternate pattern
of orientation in the ML.
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FIGURE 6 | U-box−/− mutants present a progressive dendrite arbor disorganization and an initial increase in dendritic spines. (A–E) Fluorescent
immunohistochemistry on 8 µm sagittal cryosections of wild-type (A,C, and top E) and mutant (B,D, and bottom E) fish using Parvalbumin as a marker for Purkinje
cells. The diagrams on top of (a–d) columns show the localization, orientation and structure of the underlying pictures. (A–Da) are slide scanner acquisitions
showing the general anatomy of the brain, and (A–Db) are close-ups of the cerebellum from the same pictures. (A–Dc) are maximum z-projections of confocal
stacks centered on the molecular layer of the posterior cerebellum, and (A–Dd) are the 3D renderings of neuronal tracing analysis on the stacks presented in c. The
adjacent color bars on the right (e) highlight trends in the dendrite orientation along the proximal-distal axis of the molecular layer, each quantified as the histogram
area for the distal part of the molecular layer and indicated time points (f). (E) pictures are single confocal sections presenting a zoomed view of dendritic spines in
the median to distal areas of the molecular layer. (F,G) present quantification results of the dendrite diameter (F) and the number of dendritic spines (G) at the two
time-points as means ± standard deviations (∗p < 0.05 and ∗∗p < 0.01, Student’s t-test). Scale bars in (A–D): 400 µm in a, 100 µm in b and 30 µm in (c–d). Scale
bars in (E): 2,5 µm.
Next, we investigated the detailed complexity of Purkinje cell
dendrites (wild-type: n = 3; mutant: n = 3) by using different
morphometric parameters. We observed similar dendrite
diameter between genotypes (Figures 6E,F and Table 2),
indicating no significant swelling or shrinking of the dendrites
although standard deviation was higher in data from mutants
compared to the controls suggesting greater variability. We also
noticed a trend toward an increased number of spines on the
U-box−/− dendrites compared to the wild-type at both ages
examined (Figures 6E,G and Table 2), although this increase
only appeared to be statistically significant at the 6-month time
point (t-test, p = 0.024).
Purkinje Cell Bodies of U-Box−/− Fish
Are Smaller and Fewer in Number
Quantification of the Purkinje cell bodies in wild-type and
U-box−/− cerebellum showed a significant loss in the mutants at
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TABLE 2 | Morphological properties of Purkinje cells in wild-type and U-box−/−
fish at indicated time points.
Age (month) 6 24
Dendrite diameter (µm) U-box+/+ 1.3 ± 0.04 1.43 ± 0.04
U-box−/− 1.65 ± 0.03 1.36 ± 0.11
Number of dendritic spines
(Spines/µm)
U-box+/+ 1.1 ± 0.28 2.06 ± 0.14
U-box−/− 1.86 ± 0.13 2.59 ± 0.19
Number of cell bodies U-box+/+ 272 ± 35 314 ± 22
U-box−/− 199 ± 30 223 ± 44
Cross sectional cell body area
(µm2)
U-box+/+ 51.73 ± 20.8 63.55 ± 23.6
U-box−/− 54.25 ± 22.32 45.43 ± 20.95
Data shown are means ± standard deviations.
6 and 24 months of age. The number of cell bodies decreased by
26.83% at 6 months (t-test, p = 0.012) and by 28.98% at 24 months
(t-test, p = 0.013) in the U-box−/− fish (Figures 7Aa,Ab,Ba,Bb,C
and Table 2). We also measured the size of Purkinje cell
bodies in wild-type and mutant fish. No significant differences
could be observed at 6 months (Figures 7Aa,Ba,D and
Table 2). However, at 24 months we observed irregular shaped
cell bodies and a 31.6% reduction in cell body area (t-
test, p = 1.6e-14) for the mutant Purkinje cells (n = 382)
compared to the wild-types (n = 116) (Figures 7Ab,Bb,D and
Table 2).
U-Box−/− Fish Exhibit Defects in Protein
Quality Control
We investigated the effect of Chip functional deficiency on 26S
proteasome activity and protein oligomerization in zebrafish
brains (n = 4) at 6 and 24 months of age. Total activity
of the 26S proteasome declined at 24 months compared to
6 months in both wild-type (t-test, p = 0.006) and mutant fish
(t-test, p = 0.0002, Figure 8A) groups, which is in line with
the previously reported age-dependent decrease in proteasome
activity of human and other vertebrates (Dasuri et al., 2009;
Kelmer Sacramento et al., 2020). No differences were evident
in the proteasome activity of U-box−/− compared to the wild-
type fish brains at a 6-month time point. However, a significant
reduction was demonstrated in 26S proteasome activity of
24 months old U-box−/− brains compared to their wild-type
siblings (t-test, p = 0.036, Figure 8A).
We assessed protein oligomerization in U-box−/− fish
as another indicator of a damaged protein quality control
system, using a recently developed anti-oligomer (A11) antibody
that recognizes oligomers of Aß, polyQ, prion, and insulin
(Kayed et al., 2003). Dot blot analysis using the A11 antibody
showed no significant difference in oligomer abundance in
U-box−/− brain lysates compared to wild-type controls at 6
and 24 months (Figure 8B and Supplementary Figure 2).
In addition, examination of protein expression for other
substrates of CHIP including the glutamate-binding subunit
of N-methyl-D aspartate Receptor, NR2A, Hsp70 and ataxin-
3 by immunohistochemistry of wild-type (n = 3) and mutant
(n = 6) zebrafish brain sections at 24 months did not reveal any
changes in response to the truncation of U-box domain in Chip
(Supplementary Figure 3). Taken together, these results suggest
a negative effect on cellular proteasome activity, caused by the
U-box truncation of the mutant Chip enzyme. However, these
effects did not result in an apparent accumulation of specific
oligomers nor differences in the expression of three known CHIP
protein substrates.
Chip U-Box Truncation in Mutant Fish Is
Associated With Altered Behavior
Correlated to Less Anxiety
Behavioral changes related to anxiety were investigated for the
wild-type and U-box−/− fish at 12 (n = 10) and 24 (n = 14)
months of age using the novel tank diving and light/dark
preference tests (Figure 9). In the novel tank diving test,
homozygous mutant fish spent significantly more time in the
top third of the tank compared to their wild-type siblings at
12 (t-test: p = 0.0007, Figure 9A) and 24 (t-test: p = 0.0002,
Figure 9E) months of age, indicating reduced anxiety-like
behavior in U-box−/− fish. We also observed a significant
increase in the average swimming velocity in the 24 months
old U-box−/− fish compared to the wild-type controls (t-test:
p = 0.0374, Figure 9G). Further analysis of these data showed
no significant differences in latency to enter the top 25% of the
novel tank for the wild-type and mutant fish at 12 and 24 months
(Supplementary Figure 4). This indicates that these fish explore
the tank and enter the top zone in a similar manner, although
the mutant fish tend to stay longer at the top of the tank.
There were also no significant differences between the fish in
traveled distance in the novel tank (Figures 9B,F) and the amount
of time spent in the white zone in light/dark preference test
(Figures 9D,H). We further investigated locomotion behavior
in the open field test, where the fish of different genotypes
showed similar activities in terms of total traveled distance,
average velocity, and angular velocity at 12 and 24 months of age
(Supplementary Figure 5).
DISCUSSION
Mutations in the STUB1 gene cause recessive spinocerebellar
ataxia type 16 (SCAR16) and dominant spinocerebellar ataxia
type 48 (SCA48) in humans (Ravel et al., 2021). Alterations
in the CHIP U-box domain has previously been reported to
cause severe biochemical defects as well as additional clinical
manifestations for the SCAR16 variants including Thr246Met
(Heimdal et al., 2014; Shi et al., 2014; Pakdaman et al., 2017) and
Met240Thr (Madrigal et al., 2019). Therefore, the U-box domain
seems to play a significant role in the pathogenesis of CHIP,
and in the present study, we aimed to characterize the effects
of truncation of this domain in zebrafish. Using CRISPR/Cas9
technique, we generated a mutation in the zebrafish stub1 that
caused a truncation of the Chip U-box domain. Characterization
of the homozygous mutant zebrafish revealed impaired Chip
ubiquitin ligase activity, associated with reduced body size,
disturbances of cerebellar Purkinje cells and behavioral changes.
Phenotypes were observed mainly at adult stages, while mutant
fish showed apparently normal development during embryo,
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FIGURE 7 | The number and size of Purkinje cell bodies are progressively reduced in U-box−/− fish. Fluorescent immunohistochemistry on 8 µm sagittal
cryosections on wild-type (A) and mutant (B) at 6 (a) and 24 (b,b’) months fish using Parvalbumin as a marker for Purkinje cells. (C,D) present quantification results
for the average number of Purkinje cell bodies (C) and average cell body cross-section area (D) at the two time-points as means ± standard deviations. Statistically
significant differences are shown by asterisks (∗p < 0.05 and ∗∗∗p < 0.001 Student’s t-test). Scale bars in (A,B): 10 µm.
larval and juvenile stages. These data indicate that loss of the
Chip U-box domain might not interfere with early development,
possibly due to the presence of other proteins and mechanisms
that are able to compensate for the loss of normal Chip function
enabling relatively normal growth and cellular development.
Observations reported in human SCA48 patients with CHIP-
mediated ataxias (De Michele et al., 2020) point to adult-onset
phenotypes, while mice models of CHIP deficiency were reported
to mainly show normal early development (Dai et al., 2003). It is
likely, that with time, the impaired protein quality control system
leads to the gradual loss of neurons, a hallmark of the progressive
nature of several neurodegenerative diseases, and thus primarily
later phenotype manifestationsin our mutant fish.
Sequence alignment showed the presence of identical amino
acids in the CHIP binding sites for chaperones and E2 ubiquitin
conjugating enzymes as well as a similar dimerization interface
at the U-box domain across mouse and zebrafish orthologs,
based on the position of functional residues previously identified
in crystal structures of mouse and zebrafish CHIP (Zhang
et al., 2005; Xu et al., 2006). We showed that zebrafish Chip
has ubiquitin ligase activity on Chip and Hsc70 substrates
similar to the human ortholog. This strongly indicates the
presence of conserved interactions with the E2 conjugating
enzyme through the C-terminal (U-box domain) as well as
with the chaperones via its N-terminal (TPR domain) to
mediate the transfer of ubiquitin both to itself and to the
substrates. It could be speculated that the apparent lower
ubiquitination activity toward the Hsc70 substrate for the
zebrafish Chip compared to human CHIP (Figures 1C, 2E)
indicates potential differences in their catalytic activity resulting
from variations in the amino acid sequence of the N-terminal
substrate-binding domain. However, further studies of the CHIP
binding properties of the two orthologs are needed before firm
conclusions can be drawn.
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FIGURE 8 | Reduced 26S proteasome activity was detected in U-box−/− fish. (A) Chymotrypsin-like activity was measured in brain tissues of U-box−/− and
wild-type fish at 6 and 24 months (n = 4). Statistically significant differences are shown by asterisks (∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001, Student’s t-test).
(B) Oligomer expression quantified from dot blot analysis in brain tissues of U-box−/− and wild-type fish at 6 and 24 months (n = 3). Data shown are means and
error bars indicate standard deviations.
A previous study in humans indicated high STUB1 mRNA
expression in skeletal muscle and heart, and to a lesser extent
in pancreas and brain (Ballinger et al., 1999). In contrast, we
observed the highest levels of stub1 in the zebrafish adult brain
as well as eggs and testes. The high amount of stub1 transcripts in
the eggs and testes is interesting in light of the previously reported
association with hypogonadism and reproductive impairments in
some patients with SCAR16 as well as mouse models (Shi et al.,
2014). Our findings indicate telencephalon (containing cerebral
cortex and the homolog of the mammalian hippocampus) and
midbrain, cerebellum and hypothalamus as parts of the zebrafish
brain with the most stub1 transcripts. These results are consistent
with data from mouse and rat showing the highest Stub1
expression in the cerebellum, pons, medulla, hippocampus, and
cerebral cortex (Anderson et al., 2010; Shi et al., 2014), and also
with data provided by the Human Protein Atlas, where RNA
expression levels of STUB1 are reported to be higher in cerebral
cortex, hippocampus, and midbrain compared to cerebellum and
spinal cord (Uhlén et al., 2015).9 Our in situ hybridization results
on brain sections revealed stub1 mRNAs in several parts of the
cerebellum of adult zebrafish, including Purkinje cell layer. This
is consistent with previous studies in humans and mice reporting
wide expression of STUB1 in the molecular and granular layers
of cerebellum with high abundance in Purkinje cells (Anderson
et al., 2010; Shi et al., 2014).
We further studied the functional significance of Chip in
zebrafish by using a stable and viable mutant homozygous line,
containing a CRISPR/Cas9-induced deletion mutation causing
a truncation of the functional U-box domain of Chip. The
induced truncation removed critical amino acids located at
the core of the U-box interface in beta sheet 3 and alpha-
helix 10 (Figure 1B), and completely disrupted Chip ubiquitin
ligase activity toward the Hsc70 substrate. In case of self-
ubiquitination activity, we observed a band corresponding to
mono ubiquitination for mutant Chip proteins. While the origin
of this observation remains unknown, it could suggest that
9proteinatlas.org
non-specific interactions between the E2 enzyme and Chip is
sufficient to mediate the addition of one ubiquitin molecule to
the Chip, while this interaction is not strong enough to facilitate
non-covalent bindings between ubiquitin molecules and the
subsequent formation of polyubiquitin chains (Soss et al., 2011).
Immunohistochemistry of mutant brain sections with anti-
Pvalb antibody revealed significant alterations in the total
number and morphology of Purkinje cells, including Purkinje
cell dendrite morphology and growth patterns. Decreased
numbers of Purkinje cells were previously reported in the
cerebellum of compound heterozygous SCAR16 patients with
the U-box truncating mutation Glu238∗ and the Met211Ile
substitution (Bettencourt et al., 2015). Similar findings were
also reported in mouse animal models, where CHIP deficiency
resulted in Purkinje cell loss and an increased number of
pyknotic nuclei as well as severe dendritic swelling, mimicking
phenotypes of human patients with disordered ubiquitination
(Shi et al., 2014). There is a high degree of conservation
reported for the cytoarchitecture and connectivity of cerebellar
neurons between mammals and teleost fish (Hashimoto and
Hibi, 2012). Cerebellar Purkinje neurons are one of the key
neuron types in the cerebellum with characteristic planar fan-
shaped dendrites extending into the ML. These dendrites are
arranged to fill spaces with little overlap, a configuration that
has been found to be essential for formation of numerous
synapses with more than 100,000 parallel fibers and with each
climbing fiber (Fujishima et al., 2018). Our observed changes
to dendritic growth patterns and morphology in the mutants
indicate a disturbance in their stereotypic organization, growth
and branching. We also observed trends of increased number
of dendritic spines and dendritic swelling in the mutant fish.
Such changes can possibly have a significant impact on the
relative amounts of excitatory inputs to the Purkinje neurons, and
consequently the Purkinje cell outputs to the vestibular nucleus.
In addition, biogenesis and homeostatic plasticity of dendritic
synapses are known to be regulated by ubiquitin pathways
(Mabb and Ehlers, 2010). Changes in synaptic activity result
in ubiquitin-dependent regulation of synaptic proteins, which
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FIGURE 9 | U-box−/− fish exhibit less anxiety-like behavior compared to the wild-type fish. The anxiety-like behavior of wild-type and U-box−/− fish was measured
by novel tank diving and light/dark preference tests. In the novel tank diving test, the fraction of time spent in the top third zone of the novel tank (A,E), the distance
traveled (B,F), and average velocity (C,G) was quantified and compared for each genotype group (n = 10–14 per group) at 12 (A–C) and 24 months (E–G). In the
light/dark preference test, the fraction of time spent in the white zone of the tank was quantified and compared for each group (n = 10–14 per group) at 12 (D) and
24 (H) months. Data shown are the lower and upper quartiles (Q1–Q3) and the whiskers show range of values outside Q1-Q3. Statistically significant differences are
shown by asterisks (∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001, Student’s t-test).
Frontiers in Molecular Neuroscience | www.frontiersin.org 16 September 2021 | Volume 14 | Article 723912
fnmol-14-723912 September 20, 2021 Time: 14:5 # 17
Pakdaman et al. Zebrafish Chip Protein Mutant
in turn regulate downstream pathways implicated in learning
and memory (Mabb and Ehlers, 2010). Therefore, future studies
are essential to elucidate whether neurotransmission pathways
are affected by the disorganized dendrites and to investigate
the potential effect of impaired ubiquitination on the overall
cerebellar function and altered behavior in these mutant fish.
The mutant fish displayed morphological changes in Purkinje
cells that are partially overlapping with the human phenotype for
SCAR16/SCA48. In addition, MRI data indicate slight differences
in their cerebellum size compared to the wild-types suggesting
initial atrophy of the cerebellum, a hallmark of the human
phenotype. We could not confirm cell death phenotype during
analysis of cerebellum sections at this stage (Supplementary
Figure 6). However, based on the progressive nature of the
disease, we cannot exclude the possibility of a progressive
cerebellar atrophy at later stages than included in our analysis.
The anti-CHIP antibody we have used in this study could
sufficiently detect purified, recombinant zebrafish Chip during
immunoblotting assays (Figures 1C, 3E). However, despite
extensive testing of a number of commercial and custom-
made antibodies, we did not manage to identify or generate
an antibody that could specifically detect zebrafish Chip during
immunohistochemistry of brain sections. Thus, we were not able
to directly study the putative differences in the Chip protein
localization of the U-box−/− mutants compared to the wild-type
Chip in the zebrafish brain.
Interaction of CHIP with different chaperones and a broad
range of substrates makes CHIP a master regulator of various
protein networks and cellular pathways. Studies have shown the
importance of CHIP in maintaining homeostasis for a large
group of proteins associated with cell signaling, development,
neurodegeneration, and cancer (Joshi et al., 2016). CHIP has
also been implicated in the regulation of cellular senescence as
CHIP knockout mice show decreased longevity and lower total
body weight (Min et al., 2008). Reduced proteasome activity and
elevated levels of toxic oligomers were also reported in these
mice. Similarly, we have observed a significant decrease in the
body size of mutant zebrafish at the age of 12 and 24 months.
Also, the total activity for the 26S proteasome was reduced in
mutant zebrafish at 24 months although this reduction was not
associated with accumulation of oligomeric proteins such as tau
oligomers in brain tissues. To further elucidate possible effects
of the loss of ubiquitination activity in Chip, we examined if the
protein levels of some of known CHIP substrates including the
NMDA receptor NR2A, Hsp70 and ataxin-3 had been altered.
Our immunohistochemistry analyses did not show significant
alterations of these Chip substrates in mutant brain sections
(Supplementary Figure 3). We therefore hypothesize that the
lack of U-box domain function in the U-box−/− fish can possibly
be compensated for by the TPR domain, which can eliminate
some substrates through other degradation pathways thereby
maintaining normal levels of these substrates in the mutant fish.
Lysosomal degradation of α-synuclein by the TPR domain of
CHIP has previously been reported (Shin et al., 2005), and the
TPR domain has also been shown to participate in proteasomal
degradation of NR2A via direct interactions with F-box ubiquitin
ligases (Nelson et al., 2006). Further investigations into the
protein levels of additional Chip substrates in the U-box−/−
mutants, as well as null-mutants for Chip, can improve our
understanding of the selective degradation pathways for each
substrate mediated by specific domains of CHIP.
The U-box−/− zebrafish spent significantly more time
in the top zone of the novel tank, suggesting reduced
anxiety-like behavior and aberrant exploration patterns in a
novel environment. Consistent with the high levels of stub1
expression detected in the hypothalamus of the zebrafish brain
(Figure 2), such behavior could possibly reflect changes in
the hypothalamus as previously described (Wei et al., 2020).
Similarly, mice deficient for CHIP have been reported with
increased amount of time spent in the open arms of the
elevated plus maze, as well as spatial learning errors in the
Barnes maze, which could suggest hippocampal damage and
cerebellar dysfunction (Shi et al., 2014). In contrast, mammalian
models of SCAR16 harboring a CHIP-Thr246Met mutation
were reported to have increased anxiety, together with age-
dependent sensorimotor deficiencies and social and cognitive
deficits (Shi et al., 2018). In vitro findings showed that CHIP-
Thr246Met retained other co-chaperoning functions despite
being impaired for E3 ubiquitin ligase activity. Phenotypic
differences observed for the CHIP-Thr246Met mice compared
to the loss-of-function CHIP mice support the hypothesis that
disease-causing mutations do not simply reflect total loss of CHIP
activity. Similarly, the Chip proteins expressed by homozygous
mutant zebrafish models in the present study have a truncated
and non-functional U-box domain, yet are intact for the TPR
and central helical hairpin domains. Therefore, these animals
might present phenotypes different from those induced by
complete loss of Chip proteins. The recent finding that STUB1
mutations also can cause the dominant spinocerebellar ataxia
disease, SCA48, emphasizes that the underlying mechanisms
of STUB1-mediated ataxias remain poorly understood. Future
studies on Chip zebrafish models with total loss-of-function,
knock-in pathogenic mutations and potential dominant negative
mutations will be important to improve our understanding of
potential phenotypic differences caused by different types of
Chip deficiency.
In conclusion, our findings illustrate a conserved pattern
of CHIP expression and enzymatic function for human and
zebrafish orthologs. The phenotypes described for the mutant
zebrafish with truncated U-box domain are partially overlapping
with the phenotypes reported in SCAR16/SCA48 human patients
as well as mammalian models of CHIP deficiency. These data
could open new doors for the potential use of zebrafish in
modeling STUB1-related cerebellar ataxias.
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